Zebin Wang

2.9k citations

49 papers · 2.2k indexed · 1 hit paper · h-index 19

Impact in

Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
Oncology top 5%
- PARP inhibition in cancer therapy

Papers in ⓘ

Molecular Biology 23
- FOXO transcription factor regulation 9
Oncology 16
- PARP inhibition in cancer therapy 5
- Inflammatory Biomarkers in Disease Prognosis 4

Co-authors: Pradip Raychaudhuri (10 shared papers)Janai R. Carr (7 shared papers)Nissim Hay (5 shared papers)Hyun Jung Park (5 shared papers)Angela L. Tyner (8 shared papers)Robert H. Costa (4 shared papers)Eric L. Allen (2 shared papers)Michelle Clasquin (2 shared papers)
Journals: Renal Failure (4 papers)Cancer Research (4 papers)Oncotarget (2 papers)Cancer Cell (2 papers)Scientific Reports (1 paper)
Partner nations: China United States Canada

In The Last Decade

Zebin Wang

44 papers receiving 2.1k citations

Hit Papers

align trajectories log scale

Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer 2013 · 677 citations

Peers

Countries citing papers authored by Zebin Wang

Since Specialization

Citations

This map shows the geographic impact of Zebin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zebin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zebin Wang more than expected).

Fields of papers citing papers by Zebin Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zebin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zebin Wang. The network helps show where Zebin Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Zebin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zebin Wang Line = papers co-authored together Zebin Wang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer Cancer Cell ·Krushna C. Patra, Qi Wang, Prashanth T. Bhaskar, Luke Miller, Zebin Wang, Will Wheaton, Navdeep S. Chandel, Markku Laakso, William J. Muller, Eric L. Allen, Abhishek Jha, Gromoslaw A. Smolen, Michelle Clasquin, R. Brooks Robey, Nissim Hay Hit paper breakdown →	2013	677
2	FoxM1, a critical regulator of oxidative stress during oncogenesis The EMBO Journal ·Hyun Jung Park, Janai R. Carr, Zebin Wang, Véronique Nogueira, Nissim Hay, Angela L. Tyner, Lester F. Lau, Robert H. Costa, Pradip Raychaudhuri	2009	193
3	Niraparib activates interferon signaling and potentiates anti-PD-1 antibody efficacy in tumor models Scientific Reports ·Zebin Wang, Kaiming Sun, Yonghong Xiao, Bin Feng, Keith Mikule, XiaoYan Ma, Ningping Feng, Christopher P. Vellano, Lorenzo Federico, Joseph R. Marszalek, Gordon B. Mills, Jeffrey H. Hanke, Sridhar Ramaswamy, Jing Wang	2019	178
4	FoxM1 Mediates Resistance to Herceptin and Paclitaxel Cancer Research ·Janai R. Carr, Hyun Jung Park, Zebin Wang, Megan M. Kiefer, Pradip Raychaudhuri	2010	153
5	Deregulation of FoxM1b leads to tumour metastasis EMBO Molecular Medicine ·Hyun Jung Park, Galina A. Gusarova, Zebin Wang, Janai R. Carr, Jing Li, KH Kim, Jin Qiu, Yoon‐Dong Park, Peter R. Williamson, Nissim Hay, Angela L. Tyner, Lester F. Lau, Robert H. Costa, Pradip Raychaudhuri	2010	121
6	A comparative pharmacokinetic study of PARP inhibitors demonstrates favorable properties for niraparib efficacy in preclinical tumor models Oncotarget ·Kaiming Sun, Keith Mikule, Zebin Wang, Grace K. Poon, Aparajitha Vaidyanathan, Gillian Smith, Zhi-Yi Zhang, Jeffrey H. Hanke, Sridhar Ramaswamy, Jing Wang	2018	115
7	A Conserved Phosphorylation Site within the Forkhead Domain of FoxM1B Is Required for Its Activation by Cyclin-CDK1 Journal of Biological Chemistry ·Yi–Ju Chen, Carmen Dominguez‐Brauer, Zebin Wang, John M. Asara, Robert H. Costa, Angela L. Tyner, Lester F. Lau, Pradip Raychaudhuri	2009	83
8	FoxM1 in Tumorigenicity of the Neuroblastoma Cells and Renewal of the Neural Progenitors Cancer Research ·Zebin Wang, Hyun Jung Park, Janai R. Carr, Yi–Ju Chen, Yu Zheng, Jing Li, Angela L. Tyner, Robert H. Costa, Srilata Bagchi, Pradip Raychaudhuri	2011	80
9	Essential roles of FoxM1 in Ras-induced liver cancer progression and in cancer cells with stem cell features Journal of Hepatology ·Dragana Kopanja, Akshay Pandey, Megan M. Kiefer, Zebin Wang, Neha Chandan, Janai R. Carr, Roberta Franks, Dae‐Yeul Yu, Grace Guzman, Ajay V. Maker, Pradip Raychaudhuri	2015	76
10	FoxM1 Regulates Mammary Luminal Cell Fate Cell Reports ·Janai R. Carr, Megan M. Kiefer, Hyun Jung Park, Jing Li, Zebin Wang, Joel Fontanarosa, Danielle DeWaal, Dragana Kopanja, Elizaveta V. Benevolenskaya, Grace Guzman, Pradip Raychaudhuri	2012	59
11	Protein Tyrosine Kinase 6 Directly Phosphorylates AKT and Promotes AKT Activation in Response to Epidermal Growth Factor Molecular and Cellular Biology ·Yu Zheng, Maoyu Peng, Zebin Wang, John M. Asara, Angela L. Tyner	2010	53
12	Exploitation of Diagnostic Computed Tomography Scans to Assess the Impact of Nutrition Support on Body Composition Changes in Respiratory Failure Patients Journal of Parenteral and Enteral Nutrition ·Carol A. Braunschweig, Patricia Sheean, Sarah J. Peterson, Sandra Gomez Perez, Sally Freels, Karen L. Troy, Folabomi Ajanaku, Ankur Patel, Joy S. Sclamberg, Zebin Wang	2013	49
13	PTK6 Activation at the Membrane Regulates Epithelial–Mesenchymal Transition in Prostate Cancer Cancer Research ·Yu Zheng, Zebin Wang, Wenjun Bie, Patrick M. Brauer, Bethany E. Perez White, Jing Li, Véronique Nogueira, Pradip Raychaudhuri, Nissim Hay, Debra A. Tonetti, Virgilia Macias, Andre Kajdacsy‐Balla, Angela L. Tyner	2013	40
14	Parthenolide alleviates peritoneal fibrosis by inhibiting inflammation via the NF-κB/ TGF-β/Smad signaling axis Laboratory Investigation ·Ying Zhang, Weidong Feng, Peng Xuan, Liya Zhu, Zebin Wang, Hua Shen, Chaojiang Chen, Long Xiao, Shuting Li, Yunyi Zhao, Muyi Lin, Ying Huang, Haibo Long, Jianbo Liang	2022	38
15	Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer Cancer Cell ·Krushna C. Patra, Qi Wang, Prashanth T. Bhaskar, Luke Miller, Zebin Wang, Will Wheaton, Navdeep S. Chandel, Markku Laakso, William J. Muller, Eric L. Allen, Abhishek Jha, Gromoslaw A. Smolen, Michelle Clasquin, R. Brooks Robey, Nissim Hay	2013	29
16	PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors Oncotarget ·Maoyu Peng, Rajyasree Emmadi, Zebin Wang, Elizabeth L. Wiley, Peter H. Gann, Seema A. Khan, Nilanjana Banerji, William C. McDonald, Szilárd Asztalos, Thao D. Pham, Debra A. Tonetti, Angela L. Tyner	2014	24
17	Adsorption of Soy Protein Isolate in Oil‐in‐Water Emulsions: Difference Between Native and Spray Dried Isolate Journal of the American Oil Chemists Society ·Maneephan Keerati‐u‐rai, Zebin Wang, Milena Corredig	2011	23
18	Identification of Candidate B-Lymphoma Genes by Cross-Species Gene Expression Profiling PLoS ONE ·Van S. Tompkins, Seong‐Su Han, Alicia K. Olivier, Sergei Syrbu, Thomas Bair, Anna M. Button, Laura Jacobus, Zebin Wang, Samuel Lifton, Pradip Raychaudhuri, Herbert C. Morse, George J. Weiner, Brian K. Link, Bruce A. Smith, Siegfried Janz	2013	22
19	Preclinical characterization of dostarlimab, a therapeutic anti-PD-1 antibody with potent activity to enhance immune function in in vitro cellular assays and in vivo animal models mAbs ·Sujatha Kumar, Srimoyee Ghosh, Geeta Sharma, Zebin Wang, Marilyn R. Kehry, Margaret H. Marino, Tamlyn Y. Neben, Sharon Lu, Shouqi Luo, Simon Roberts, Sridhar Ramaswamy, Hadi Danaee, David W. Jenkins	2021	19
20	Targeting FoxM1 Effectively Retards p53-Null Lymphoma and Sarcoma Molecular Cancer Therapeutics ·Zebin Wang, Yu Zheng, Hyun-Jung Park, Jing Li, Janai R. Carr, Yi–Ju Chen, Megan M. Kiefer, Dragana Kopanja, Srilata Bagchi, Angela L. Tyner, Pradip Raychaudhuri	2013	18

About Zebin Wang

Zebin Wang is a scholar working on Molecular Biology, Oncology, Nephrology, Surgery and Cardiology and Cardiovascular Medicine, having authored 49 papers that have together received 2.2k indexed citations. Recurring topics across this work include FOXO transcription factor regulation (9 papers), Dialysis and Renal Disease Management (7 papers), PARP inhibition in cancer therapy (5 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers), Heart Failure Treatment and Management (4 papers), Parathyroid Disorders and Treatments (4 papers), Renal Diseases and Glomerulopathies (3 papers) and Pancreatic function and diabetes (3 papers). The work is most often cited by research in Cancer Research (659 citations), Oncology (692 citations), Molecular Biology (1.5k citations), Aging (22 citations) and Pathology and Forensic Medicine (205 citations). Zebin Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Pradip Raychaudhuri, Janai R. Carr, Nissim Hay, Hyun Jung Park, Angela L. Tyner, Robert H. Costa, Eric L. Allen, Michelle Clasquin, Qi Wang and R. Brooks Robey. Their work appears in journals such as Renal Failure, Cancer Research, Oncotarget, Cancer Cell and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact